ANA Test and ENA Test in Autoimmune Diseases Diagnosis
by Dr Anindita Santosa
When doctors suspect an autoimmune condition, two common blood tests often come up: the ANA (antinuclear antibody) and the ENA (extractable nuclear antigen) tests. Many patients find these results confusing — and that’s understandable. These tests can give us important clues, but they are not “yes or no” answers by themselves.
🔹 ANA test: Looks for antibodies that target the nucleus of our cells. A positive result can be seen in conditions like lupus or Sjögren’s syndrome. But here’s the twist: some perfectly healthy people can also test weakly positive, especially at low levels.
🔹 ENA panel: If the ANA is positive, this follow-up test looks for more specific antibodies, such as Anti-Ro/SSA, Anti-La/SSB, or Anti-Smith. These results can help point us toward particular autoimmune conditions, but even then, they’re just pieces of the puzzle.
⚠️ Limitations: Both ANA and ENA can have false positives (showing a result when disease isn’t there) or false negatives (missing disease when it is present). Results can also vary depending on the lab. That’s why doctors never interpret these in isolation — we always combine them with your symptoms, medical history, examination, and sometimes other investigations.
💡 If you’ve had these tests, some useful questions to ask your doctor are:
-
What do these results mean in the context of my symptoms?
-
Do I need further tests?
-
Should this test be repeated, and if so, how often?
Remember: blood tests are guides, not verdicts. They can point us in the right direction, but your story and lived experience are just as important in making the right diagnosis.
#AutoimmuneTesting #ANA #ENA #DiagnosticJourney #AariaClinic #SingaporeHealthcare
About the Author
Dr. Anindita Santosa is a Rheumatologist, Allergist, and Clinical Immunologist dedicated to reimagining the way specialty care is delivered across the globe. With a career spanning patient care, academic leadership, and health innovation, she combines scientific rigor with a visionary outlook to bridge the gap between medicine and technology.
As Medical Director of Aaria Rheumatology in Singapore, Dr. Santosa leads with a holistic, patient-first philosophy, ensuring individuals with complex autoimmune and immunological conditions receive care that is compassionate, equitable, and evidence-based. She also serves as Deputy Chairman of the National Arthritis Foundation, advocating for patient empowerment and community-centered approaches to chronic disease.
